Process for producing a contrast agent
AssigneeSanochemia Pharmazeutika AG
InventorsStefan WELZIG, Beate KÄLZ, József GUNGL, Klaus GERDES, Roswitha BRAUNRATH, Christina ABRAHAMSBERG
Life of this patent
Estimating the term…
Loading patent…
AssigneeSanochemia Pharmazeutika AG
InventorsStefan WELZIG, Beate KÄLZ, József GUNGL, Klaus GERDES, Roswitha BRAUNRATH, Christina ABRAHAMSBERG
Estimating the term…
A method produces an aqueous liquid preparation for magnetic resonance contrast that contains a complex of a lanthanide and a macrocyclic chelate together with free chelate. A solution of the macrocyclic chelate in water is prepared, lanthanide and meglumine are added, and complex formation proceeds in the presence of meglumine at a pH between 6.5 and 8.0 with lanthanide in molar excess over meglumine and meglumine in molar excess over the chelate. The pH is then reduced to a target value below 5.0 by incremental addition of an acid such as further chelate, optionally followed by addition of a fixed chelate amount. The pH is subsequently raised above 6.5 with meglumine and the solution is diluted to a final volume, providing an industrial-scale single-vessel process that yields a preparation containing a defined low amount of free lanthanide.
A method for producing an aqueous liquid preparation containing, as contrast agent for magnetic resonance, a complex of a lanthanide and a macrocyclic chelate, the preparation containing free macrocyclic chelate, the method comprising:
A method for producing an aqueous liquid preparation containing, as contrast agent for magnetic resonance, a complex of gadolinium and DOTA, the preparation containing free DOTA, the method comprising:
A method for producing an aqueous liquid preparation containing, as contrast agent for magnetic resonance, a complex of gadolinium and DOTA, the preparation containing free DOTA, the method comprising:
Dependencies are inferred from the claim text.